d614g s1 (Sino Biological)


Name:
SARS CoV 2 2019 nCoV Spike S1 D614G ECD Fc Recombinant Protein
Description:
A DNA sequence encoding the SARS CoV 2 2019 nCoV Spike S1 D614G Fc Recombinant Protein YP 009724390 1 Val16 Arg685 D614G was expressed with the Fc region of human IgG1 at the C terminus
Catalog Number:
40591-v02h3
Price:
None
Category:
recombinant protein
Product Aliases:
coronavirus spike Protein 2019-nCoV, cov spike Protein 2019-nCoV, ncov RBD Protein 2019-nCoV, ncov s1 Protein 2019-nCoV, ncov s2 Protein 2019-nCoV, ncov spike Protein 2019-nCoV, NCP-CoV RBD Protein 2019-nCoV, NCP-CoV s1 Protein 2019-nCoV, NCP-CoV s2 Protein 2019-nCoV, NCP-CoV Spike Protein 2019-nCoV, novel coronavirus RBD Protein 2019-nCoV, novel coronavirus s1 Protein 2019-nCoV, novel coronavirus s2 Protein 2019-nCoV, novel coronavirus spike Protein 2019-nCoV, RBD Protein 2019-nCoV, S1 Protein 2019-nCoV, S2 Protein 2019-nCoV, Spike RBD Protein 2019-nCoV
Host:
HEK293 Cells
|
Buy from Supplier |
Structured Review

A DNA sequence encoding the SARS CoV 2 2019 nCoV Spike S1 D614G Fc Recombinant Protein YP 009724390 1 Val16 Arg685 D614G was expressed with the Fc region of human IgG1 at the C terminus
https://www.bioz.com/result/d614g s1/product/Sino Biological
Average 94 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Membrane Nanoparticles Derived from ACE2-rich Cells Block SARS-CoV-2 Infection"
Article Title: Membrane Nanoparticles Derived from ACE2-rich Cells Block SARS-CoV-2 Infection
Journal: bioRxiv
doi: 10.1101/2020.08.12.247338

Figure Legend Snippet: Inhibition of HEK-293T-hACE2 NPs on SARS-CoV-2 D614G-S1. (a) Binding kinetics for ACE2 and D614G-S1 loaded on SA biosensors. The fitting curves are in red. (b) Binding kinetics for increasing concentrations of HEK-293T-hACE2 NPs and D614G-S1 loaded on SA biosensors. (c) Immunofluorescence microscopy revealing the protection of HEK-293T-hACE2 NPs on HK-2 cells exposed to D614G-S1 (green). Nuclei are stained using DAPI (blue). Scale bar indicates 20 μm.
Techniques Used: Inhibition, Binding Assay, Immunofluorescence, Microscopy, Staining
2) Product Images from "Membrane Nanoparticles Derived from ACE2-rich Cells Block SARS-CoV-2 Infection"
Article Title: Membrane Nanoparticles Derived from ACE2-rich Cells Block SARS-CoV-2 Infection
Journal: bioRxiv
doi: 10.1101/2020.08.12.247338

Figure Legend Snippet: Inhibition of HEK-293T-hACE2 NPs on SARS-CoV-2 D614G-S1. (a) Binding kinetics for ACE2 and D614G-S1 loaded on SA biosensors. The fitting curves are in red. (b) Binding kinetics for increasing concentrations of HEK-293T-hACE2 NPs and D614G-S1 loaded on SA biosensors. (c) Immunofluorescence microscopy revealing the protection of HEK-293T-hACE2 NPs on HK-2 cells exposed to D614G-S1 (green). Nuclei are stained using DAPI (blue). Scale bar indicates 20 μm.
Techniques Used: Inhibition, Binding Assay, Immunofluorescence, Microscopy, Staining
Related Articles
other:Article Title: Membrane Nanoparticles Derived from ACE2-rich Cells Block SARS-CoV-2 Infection Article Snippet: Biotinylated SARS-CoV-2 RBD and D614G-S1 were obtained with a G-MM-IGT biotinylation kit (Genemore, Shanghai, CHN) was immobilized on SA biosensors at 15 μg mL−1 . Binding Assay:Article Title: Membrane Nanoparticles Derived from ACE2-rich Cells Block SARS-CoV-2 Infection Article Snippet: .. Association was performed at a shaking speed of 1000 rpm and ran for 300 s. To determine the affinity of ACE2 binding to Purification:Article Title: BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2 Article Snippet: A recombinant SARS-CoV-2 RBD containing a C-terminal Avitag™ (Acro Biosystems) was used as a target antigen in Luminex immunoassays. .. Purified Recombinant:Article Title: BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2 Article Snippet: A recombinant SARS-CoV-2 RBD containing a C-terminal Avitag™ (Acro Biosystems) was used as a target antigen in Luminex immunoassays. .. Purified Article Title: Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters Article Snippet: Binding characterizationELISA plates (Nunc MaxiSorp; Thermo Fisher Scientific, Grand Island, NY) were coated with recombinant SARS-CoV-2 proteins at 1□μg/ml. .. Recombinant proteins used include SARS-CoV-2 S1+S2 (Sino Biological, Wayne, PA), Enzyme-linked Immunosorbent Assay:Article Title: BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2 Article Snippet: A recombinant SARS-CoV-2 RBD containing a C-terminal Avitag™ (Acro Biosystems) was used as a target antigen in Luminex immunoassays. .. Purified Mouse Assay:Article Title: BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2 Article Snippet: A recombinant SARS-CoV-2 RBD containing a C-terminal Avitag™ (Acro Biosystems) was used as a target antigen in Luminex immunoassays. .. Purified |